Adenosine vs. Diltiazem
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT07456423
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Sponsor
- Haseki Training and Research Hospital
- Registry
-
NCT07456423
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT07456423. Randomized; single masking; primary purpose treatment. Start 2024-07-01 (actual); primary completion 2025-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Adenosine vs. Diltiazem
- Acronym
- AVNRTstdy
- Condition
- Supraventricular Tachycardia (SVT)
- Condition
- Atrioventricular Nodal Re Entrant Tachycardia
- Intervention (Drug)
- Adenosine intravenous
- Intervention (Drug)
- Diltiazem intravenous
- Lead sponsor
- Haseki Training and Research Hospital
Record details
- Record id
cardio:ct-nct07456423- Content hash
351395e41e59f2a465aa7b710f20fdc7aa79e5a6440c1a22b867f67cc2b68ed0